Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lu-177-DOTAGA-IAC |
Trade Name | |
Synonyms | Lu-177-avb3-IAC|Lutetium Lu-177-DOTAGA-IAC|HurlutinTM Lu-177 |
Drug Descriptions |
Lu-177-DOTAGA-IAC is a radioconjugate comprising the radionuclide Lutetium-177 conjugated to a peptidomimetic molecule that targets integrin Avb3, which potentially delivers radionuclide therapy to Avb3-expressing tumors (Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2879). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lu-177-DOTAGA-IAC | Lu-177-DOTAGA-IAC | 0 | 1 |